Company Filing History:
Years Active: 2021-2024
Title: Innovations by Robert Lundqvist
Introduction
Robert Lundqvist is a notable inventor based in Hälsö, Sweden. With a strong focus on pharmaceutical innovations, he has successfully filed for five patents, contributing to advancements in the treatment of liver diseases.
Latest Patents
Among Lundqvist's latest patents is the invention concerning crystal modifications of odevixibat. This invention, specifically crystal modifications 1 and 2, details a process for preparing crystal modification 1, along with a pharmaceutical composition that includes this modification for treating various medical conditions.
Another significant patent from Lundqvist concerns a pharmaceutical formulation of odevixibat, tailored for pediatric use. This formulation consists of small particles and is aimed at treating liver diseases, particularly bile acid-dependent liver diseases such as biliary atresia, progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome (ALGS), and pediatric cholestatic pruritus. It also outlines a process for preparing this specific pharmaceutical formulation.
Career Highlights
Robert Lundqvist has worked for Albireo AB, a company dedicated to developing innovative therapies for liver diseases. His role involves significant research and development, which has led to his contributions in the field of pharmaceuticals and biotechnology.
Collaborations
Throughout his career, Lundqvist has collaborated with skilled professionals such as Ingvar Ymen and Eva Byröd. These collaborations have propelled his research endeavors and have been instrumental in the successful development of his inventions.
Conclusion
Robert Lundqvist's work exemplifies the vital role of innovation in the medical field, particularly in advancing treatments for complex liver diseases. His contributions continue to make a significant impact in pharmaceutical research and have the potential to enhance patient care significantly.